Skip to content
NOWCAST 비바카지노 Viva News at 6:00pm Saturday
Live Now
코인카지노

Supreme Court unanimously preserves access to widely used abortion medication

Supreme Court unanimously preserves access to widely used abortion medication
코인카지노
Supreme Court unanimously preserves access to widely used abortion medication
The Supreme Court on Thursday unanimously preserved access to a medication that was used in nearly two-thirds of all abortions in the U.S. last year, in the court맥스카지노s first abortion decision since conservative justices overturned Roe v. Wade two years ago.The nine justices ruled that abortion opponents lacked the legal right to sue over the federal Food and Drug Administration맥스카지노s approval of the medication, mifepristone, and the FDA's subsequent actions to ease access to it. The case had threatened to restrict access to mifepristone across the country, including in states where abortion remains legal.Justice Brett Kavanaugh, who was part of the majority to overturn Roe, wrote for the court on Thursday that 맥스카지노federal courts are the wrong forum for addressing the plaintiffs맥스카지노 concerns about FDA맥스카지노s actions."The decision could lessen the intensity of the abortion issue in the November elections, with Democrats already energized and voting against restrictions on reproductive rights.But the high court is separately considering another abortion case, about whether a federal law on emergency treatment at hospitals overrides state abortion bans in rare emergency cases in which a pregnant patient맥스카지노s health is at serious risk.More than 6 million people have used mifepristone since 2000. Mifepristone blocks the hormone progesterone and primes the uterus to respond to the contraction-causing effect of a second drug, misoprostol. The two-drug regimen has been used to end a pregnancy through 10 weeks gestation.Health care providers have said that if mifepristone is no longer available or is too hard to obtain, they would switch to using only misoprostol, which is somewhat less effective in ending pregnancies.President Joe Biden맥스카지노s administration and drug manufacturers had warned that siding with abortion opponents in this case could undermine the FDA맥스카지노s drug approval process beyond the abortion context by inviting judges to second-guess the agency맥스카지노s scientific judgments. The Democratic administration and New York-based Danco Laboratories, which makes mifepristone, argued that the drug is among the safest the FDA has ever approved.The decision 맥스카지노safeguards access to a drug that has decades of safe and effective use,맥스카지노 Danco spokeswoman Abigail Long said in a statement.The plaintiffs in the mifepristone case, anti-abortion doctors and their organizations, argued in court papers that the FDA맥스카지노s decisions in 2016 and 2021 to relax restrictions on getting the drug were unreasonable and 맥스카지노jeopardize women맥스카지노s health across the nation.맥스카지노Kavanaugh acknowledged what he described as the opponents' 맥스카지노sincere legal, moral, ideological, and policy objections to elective abortion and to FDA맥스카지노s relaxed regulation of mifepristone.맥스카지노Federal laws already protect doctors from having to perform abortions, or give any other treatment that goes against their beliefs, Kavanaugh wrote. 맥스카지노The plaintiffs have not identified any instances where a doctor was required, notwithstanding conscience objections, to perform an abortion or to provide other abortion-related treatment that violated the doctor맥스카지노s conscience since mifepristone맥스카지노s 2000 approval,맥스카지노 he wrote.In the end, Kavanaugh wrote, the anti-abortion doctors went to the wrong forum and should instead direct their energies to persuading lawmakers and regulators to make changes. Those comments pointed to the stakes of the 2024 election and the possibility that an FDA commissioner appointed by Republican Donald Trump, if he wins the White House, could consider tightening access to mifepristone.The mifepristone case began five months after the Supreme Court overturned Roe. Abortion opponents initially won a sweeping ruling nearly a year ago from U.S. District Judge Matthew Kacsmaryk, a Trump nominee in Texas, which would have revoked the drug맥스카지노s approval entirely. The 5th U.S. Circuit Court of Appeals left intact the FDA맥스카지노s initial approval of mifepristone. But it would reverse changes regulators made in 2016 and 2021 that eased some conditions for administering the drug.The Supreme Court put the appeals court맥스카지노s modified ruling on hold, then agreed to hear the case, though Justices Samuel Alito, the author of the decision overturning Roe, and Clarence Thomas would have allowed some restrictions to take effect while the case proceeded. But they, too, joined the court's opinion Thursday.___Associated Press writer Lindsay Whitehurst contributed to this report.

The Supreme Court on Thursday unanimously preserved access to a medication that was used in nearly two-thirds of all abortions in the U.S. last year, in the court맥스카지노s first abortion decision since conservative justices overturned Roe v. Wade two years ago.

that abortion opponents lacked the legal right to sue over the federal Food and Drug Administration맥스카지노s approval of the medication, mifepristone, and the FDA's subsequent actions to ease access to it. The case had threatened to restrict access to mifepristone across the country, including in states where abortion remains legal.

코인카지노

Justice Brett Kavanaugh, who was part of the majority to overturn Roe, wrote for the court on Thursday that 맥스카지노federal courts are the wrong forum for addressing the plaintiffs맥스카지노 concerns about FDA맥스카지노s actions."

The decision could lessen the intensity of the abortion issue in the November elections, with Democrats already energized and voting against restrictions on reproductive rights.

But the high court is separately considering another abortion case, about whether a federal law on emergency treatment at hospitals overrides state abortion bans in rare emergency cases in which a pregnant patient맥스카지노s health is at serious risk.

More than 6 million people have used mifepristone since 2000. Mifepristone blocks the hormone progesterone and primes the uterus to respond to the contraction-causing effect of a second drug, misoprostol. has been used to end a pregnancy through 10 weeks gestation.

Health care providers have said that if mifepristone is no longer available or is too hard to obtain, they would switch to using only misoprostol, which is somewhat less effective in ending pregnancies.

President Joe Biden맥스카지노s administration and drug manufacturers had warned that siding with abortion opponents in this case could undermine the FDA맥스카지노s drug approval process beyond the abortion context by inviting judges to second-guess the agency맥스카지노s scientific judgments. The Democratic administration and New York-based Danco Laboratories, which makes mifepristone, argued that the drug is among the safest the FDA has ever approved.

The decision 맥스카지노safeguards access to a drug that has decades of safe and effective use,맥스카지노 Danco spokeswoman Abigail Long said in a statement.

The plaintiffs in the mifepristone case, anti-abortion doctors and their organizations, argued in court papers that the FDA맥스카지노s decisions in 2016 and 2021 to relax restrictions on getting the drug were unreasonable and 맥스카지노jeopardize women맥스카지노s health across the nation.맥스카지노

Kavanaugh acknowledged what he described as the opponents' 맥스카지노sincere legal, moral, ideological, and policy objections to elective abortion and to FDA맥스카지노s relaxed regulation of mifepristone.맥스카지노

Federal laws already protect doctors from having to perform abortions, or give any other treatment that goes against their beliefs, Kavanaugh wrote. 맥스카지노The plaintiffs have not identified any instances where a doctor was required, notwithstanding conscience objections, to perform an abortion or to provide other abortion-related treatment that violated the doctor맥스카지노s conscience since mifepristone맥스카지노s 2000 approval,맥스카지노 he wrote.

In the end, Kavanaugh wrote, the anti-abortion doctors went to the wrong forum and should instead direct their energies to persuading lawmakers and regulators to make changes.

Those comments pointed to the stakes of the 2024 election and the possibility that an FDA commissioner appointed by Republican Donald Trump, if he wins the White House, could consider tightening access to mifepristone.

The mifepristone case began five months after the Supreme Court overturned Roe. Abortion opponents initially won a sweeping ruling nearly a year ago from U.S. District Judge Matthew Kacsmaryk, a Trump nominee in Texas, which would have revoked the drug맥스카지노s approval entirely. The 5th U.S. Circuit Court of Appeals left intact the FDA맥스카지노s initial approval of mifepristone. But it would reverse changes regulators made in 2016 and 2021 that eased some conditions for administering the drug.

The Supreme Court put the appeals court맥스카지노s modified ruling on hold, then agreed to hear the case, though Justices Samuel Alito, the author of the decision overturning Roe, and Clarence Thomas would have allowed some restrictions to take effect while the case proceeded. But they, too, joined the court's opinion Thursday.

___

Associated Press writer Lindsay Whitehurst contributed to this report.